I'm a computational biologist and complex systems scientist whose research spans precision oncology and biodefense. The central question driving my work is how biological systems fail, adapt, and resist intervention. 

As a co-founder and chief scientific officer at NNOXX—a spin-out from the Harrington Discovery Institute at Case Western—I led the development of novel digital and molecular biosensors, taking a first-to-market technology from concept to commercialization.

Since then, my focus has been on developing computational models to understand mechanisms of treatment resistance and uncover latent therapeutic vulnerabilities in cancer—recovering the joint structure of biological systems without decomposing them into independent parts or handing their complexity to a black box. 

I also serve as a scientific advisor to early-stage health and biotechnology companies, where I provide strategic guidance across biosensor development, biological data analysis/integration, and technical due diligence. 

You can read about what I’m currently learning, working on, and thinking about on Sequence & Destroy. Additionally, you can reach me at evanpeikon@gmail.com.